For startups, benefits of non-dilutive funding extend far beyond cash
Panelists at MedCity INVEST Precision Medicine said startups can gain valuable expertise and experience through the process of seeking out non-dilutive funding.
Panelists at MedCity INVEST Precision Medicine said startups can gain valuable expertise and experience through the process of seeking out non-dilutive funding.
Biobots, Freenome, LignaMed, Telesis and OriMAbs - all life sciences startups - have taken residence in Philadelphia's University Science Center accelerator. Their focuses range from cancer diagnostics to 3D bioprinting.